Found 29 matching trials
Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder
NAThe ADAPT-ED study is a two-stage, sequential multiple assignment randomize...
Location
Arrowhead Regional Medical Center
Electronic Pharmacotherapy Risk Management
N/AThe purpose of the Utah ePRM (electronic Pharmacotherapy Risk Management) p...
Location
Multi-clinic site
Behavioral and Enhanced Perinatal Intervention for Cessation (B-EPIC): Reducing Tobacco Use Among Opioid Addicted Women
NAThis study tests an intervention for tobacco cessation (named B-EPIC) in an...
Location
Baptist Health Lexington
Co-Use of Opioid Medications and Alcohol Prevention Study
NAPrevious research, including that of this team, shows that a significant po...
Location
University of Tennessee College of Medicine
Maintenance With Niraparib In Patients With Advanced Urothelial Cancer After 1st-line Platinum-based Chemotherapy
PHASE2This is a 2-arm, prospective, randomized (2:1 ratio), open-label, multi-cen...
Location
Azienda Sanitaria Locale CN2 - Alba e Bra
Mindful Body Awareness With Medication Treatment for Opioid Use Disorder
NAThe national opioid epidemic requires development of real-world evidence-ba...
Location
Cascade Medical Advantage
Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans
NAOpioid use disorder (OUD) confers a higher risk of acquiring and transmitti...
Location
Northport VA Medical Center, Northport, NY
Innovatively Increasing PCP Prescribing of Buprenorphine: Measurement Based Care and Integrated Electronic Solution
N/AThe objective of this observational feasibility project is to assess the fe...
Location
University of Texas Southwestern Medical Center
Effectiveness of a Hospital Addiction Service in Treating Opioid and Alcohol Addiction
NAHypothesis: Patients who are addicted to opioids or alcohol will have reduc...
Location
Women's College Hospital
A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder
PHASE4VA-BRAVE will determine whether a 28-day long-acting injectable sub-cutaneo...
Location
Tuscaloosa VA Medical Center, Tuscaloosa, AL